John Bradley Sorenson - Feb 14, 2023 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role: EVP, Global Operations
Signature: /s/ Susan Thompson, Attorney-in-Fact
Stock symbol: BSX
Transactions as of: Feb 14, 2023
Transactions value $: $0
Form type: 4
Date filed: 2/15/2023, 04:45 PM
Previous filing: Jan 3, 2023
Next filing: Feb 16, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BSX	Common Stock	Gift	$0	-4.78K	-12.01%	$0.00	35K	Feb 6, 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BSX	Performance Share Units	Award	$0	+4.47K		$0.00	4.47K	Feb 14, 2023	Common Stock	4.47K		Direct	F1, F2
transaction	BSX	Restricted Stock Units	Award	$0	+8.46K		$0.00	8.46K	Feb 14, 2023	Common Stock	8.46K		Direct	F3, F4
transaction	BSX	Stock Option (Right to Buy)	Award	$0	+22K		$0.00	22K	Feb 14, 2023	Common Stock	22K	$47.28	Direct	F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each performance share unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F2	On February 10, 2022, the reporting person was awarded a target number of performance share units under the Company's 2022 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person would be based on the Company's 2022 adjusted free cash flow measured against its 2022 financial plan over the one-year performance period ending December 31, 2022 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 14, 2023, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined will vest in whole upon the completion of the individual service period that ends on December 31, 2024.
F3	Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F4	Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 14, 2024, the first anniversary of the date of grant.
F5	Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 14, 2024, the first anniversary of the date of grant.